Novo plans online launch for obesity pill once approved, Bloomberg News reports
Published by Global Banking and Finance Review
Posted on October 3, 2025
1 min readLast updated: January 21, 2026
Published by Global Banking and Finance Review
Posted on October 3, 2025
1 min readLast updated: January 21, 2026
Novo Nordisk plans to launch its obesity pill online via telehealth platforms like Ro and WeightWatchers after receiving U.S. approval.
(Reuters) -Danish drugmaker Novo Nordisk said it plans to make its new obesity pill available through telehealth platforms like Ro and WeightWatchers once it gets U.S. approval, Bloomberg News reported on Friday.
(Reporting by Kamal Choudhury in Bengaluru; Editing by Alan Barona)
An obesity pill is a medication designed to help individuals lose weight by suppressing appetite, increasing feelings of fullness, or reducing the absorption of fat.
U.S. approval refers to the authorization granted by the U.S. Food and Drug Administration (FDA) for a drug to be marketed and sold in the United States after it has been deemed safe and effective.
Explore more articles in the Headlines category


